Protagonist Therapeutics (PTGX) Debt Ratio (2018 - 2023)

Protagonist Therapeutics has reported Debt Ratio for 6 years, with the latest figure at 0.0 in Q2 2023.

• Quarterly Debt Ratio fell 87.89% year-over-year to 0.0 in Q2 2023, while the trailing twelve-month figure through Jun 2023 was 0.0 (down 87.89% YoY) and the FY2022 annual result came in at 0.0, down 89.24% from the prior year.
• Debt Ratio retreated to 0.0 in Q2 2023 per PTGX's latest filing, from 0.0 in the prior quarter.
• Over five years, Debt Ratio peaked at 0.08 in Q1 2020 and troughed at 0.0 in Q2 2023.
• A 5-year average of 0.01 and a median of 0.0 in 2019 frame the typical range for Debt Ratio.
• The sharpest annual moves came in 2019 and 2022: Debt Ratio jumped 838.15% in 2019, then sank 99.09% in 2022.
• Over 5 years, Debt Ratio stood at 0.07 in 2019, then plunged by 88.2% to 0.01 in 2020, then sank by 69.29% to 0.0 in 2021, then tumbled by 89.24% to 0.0 in 2022, then sank by 88.79% to 0.0 in 2023.
• According to Business Quant data, Debt Ratio over the past three periods registered 0.0, 0.0, and 0.0 for Q2 2023, Q1 2023, and Q4 2022 respectively.